Get the Stockscreener App
1.13
6.60%
0.07
Actinium Pharmaceuticals Inc Stock (ATNM) Forecast
The Actinium Pharmaceuticals Inc (ATNM) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $1.0484, representing a -7.23% decrease from the current price of $1.13. The highest analyst price target is $2.0621, and the lowest is $0.0346.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ATNM Price Target
Average 1.2955
(+14.64% Upside)
Is Actinium Pharmaceuticals Inc (ATNM) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 52.17 | Neutral |
| STOCH(9,6) | 28.12 | Neutral |
| STOCHRSI(14) | 80.80 | Sell |
| MACD(12,26) | -0.0193 | Sell |
| ADX(14) | 19.09 | Neutral |
| William %R | -37.93 | Neutral |
| CCI(14) | 12.37 | Neutral |
Buy: 0
Sell: 2
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.0784
Buy
|
1.0811
Buy
|
| MA20 |
1.1242
Buy
|
1.1041
Buy
|
| MA50 |
1.0949
Buy
|
1.0926
Buy
|
| MA100 |
1.0345
Buy
|
1.0873
Buy
|
| MA200 |
1.1173
Buy
|
1.1642
Sell
|
Buy: 9
Sell: 1
Neutral: 0
Summary: Buy
According to our latest analysis, ATNM could be considered a Strong Buy, with 17 technical analysis indicators signaling 9 Buy signals, 3 signaling Sell signals and 5 Neutral signals. This might be a good time to open fresh positions on ATNM, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 52.17 indicates that ATNM is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 28.12 indicates that ATNM is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 80.8 indicates that ATNM is oversold. This suggests that ATNM price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 19.09 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 12.37 indicates that ATNM is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term ATNM price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Actinium Pharmaceuticals Inc financial reports and earnings history, Actinium Pharmaceuticals Inc (ATNM) stock could reach $1.6093 by 2030, $7.7748 by 2040 and $26.64 by 2050. See the projected annual prices until 2050 of the Actinium Pharmaceuticals Inc stock below:
- Actinium Pharmaceuticals Inc (ATNM) is expected to reach an average price of $3.1488 in 2035, with a high prediction of $3.3873 and a low estimate of $3.3231. This indicates an $178.66% rise from the last recorded price of $1.13.
- Actinium Pharmaceuticals Inc (ATNM) stock is projected to chart a bullish course in 2040, with an average price target of $7.9116, representing an $600.15% surge from its current level. The forecast ranges from a conservative $7.9144 to a sky-high $7.7748.
- Our analysts predict Actinium Pharmaceuticals Inc (ATNM) to jump 949.27% by 2045, soaring from $12.41 to an average price of $11.86, potentially reaching $11.80. While $12.41 is the low estimate, the potential upside is significant.
- Actinium Pharmaceuticals Inc (ATNM) stock is expected to climb by 2050, reaching an average of $26.63, a $2,257% jump from its current level. However, a wide range of estimates exists, with high and low targets of $26.64 and $26.88, respectively, highlighting the market's uncertainty.
Actinium Pharmaceuticals Inc Stock (ATNM) Year by Year Forecast
Actinium Pharmaceuticals Inc Stock (ATNM) Price Forecast for 2026
The predicted value for Actinium Pharmaceuticals Inc (ATNM) in 2026 is set at an average of $1.0484. Estimates vary from a peak of $2.0621 to a trough of $0.0346, indicating an -7.23% surge from the present price of $1.13.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| November, 2026 | $0.1064 | $0.0346 | $2.0621 | -90.59% |
| December, 2026 | $0.3194 | $0.7393 | $0.4785 | -71.74% |
Actinium Pharmaceuticals Inc Stock (ATNM) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Actinium Pharmaceuticals Inc (ATNM) is $4.697, with a high forecast of $9.2359 and a low forecast of $0.1581. This indicates an +315.66% increase from the last price of $1.13.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $1.5451 | $1.0783 | $1.1251 | +36.74% |
| February, 2027 | $1.7509 | $1.7929 | $1.3309 | +54.94% |
| March, 2027 | $1.9056 | $1.7468 | $1.6056 | +68.63% |
| April, 2027 | $1.4913 | $1.6013 | $1.3845 | +31.97% |
| May, 2027 | $0.796 | $0.1581 | $1.2102 | -29.56% |
| June, 2027 | $0.9117 | $1.0367 | $0.8017 | -19.31% |
| July, 2027 | $1.2375 | $1.1107 | $0.9775 | +9.51% |
| August, 2027 | $1.4022 | $1.3429 | $1.2454 | +24.09% |
| September, 2027 | $0.2779 | $0.4579 | $1.2444 | -75.40% |
| October, 2027 | $2.4063 | $0.3842 | $2.5563 | +112.95% |
| November, 2027 | $1.4216 | $0.7906 | $2.4974 | +25.81% |
| December, 2027 | $5.0159 | $1.0027 | $9.2359 | +343.88% |
Actinium Pharmaceuticals Inc Stock (ATNM) Price Forecast for 2028
In 2028, Actinium Pharmaceuticals Inc (ATNM) is projected to reach an average price of $5.0854, with a high projection of $9.195 and a low estimate of $0.9758. This indicates an +350.04% rise from the last price of $1.13.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $5.4912 | $3.4891 | $7.158 | +385.95% |
| February, 2028 | $4.9554 | $3.7754 | $5.7333 | +338.54% |
| March, 2028 | $5.9497 | $3.7276 | $6.2395 | +426.52% |
| April, 2028 | $8.2339 | $5.5408 | $8.9253 | +628.67% |
| May, 2028 | $3.8593 | $2.9882 | $9.195 | +241.53% |
| June, 2028 | $3.7735 | $3.2124 | $4.1603 | +233.94% |
| July, 2028 | $3.4488 | $2.9178 | $4.1546 | +205.21% |
| August, 2028 | $3.1331 | $2.6909 | $3.8798 | +177.26% |
| September, 2028 | $2.1473 | $1.9063 | $3.4341 | +90.03% |
| October, 2028 | $1.8326 | $1.7229 | $2.5895 | +62.18% |
| November, 2028 | $1.1369 | $0.9758 | $1.9037 | +0.61% |
| December, 2028 | $1.5111 | $1.238 | $2.8801 | +33.73% |
Actinium Pharmaceuticals Inc Stock (ATNM) Price Forecast for 2029
The 2029 price forecast for Actinium Pharmaceuticals Inc Stock (ATNM) is $3.1443 on average, with a high prediction of $6.2726 and a low estimate of $0.016. This represents an +178.26% increase from the previous price of $1.13.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.7165 | $0.6365 | $1.7083 | -36.60% |
| February, 2029 | $0.1093 | $0.1814 | $1.1274 | -90.33% |
| March, 2029 | $0.805 | $0.0361 | $1.065 | -28.77% |
| April, 2029 | $0.7303 | $0.016 | $1.7481 | -35.37% |
| May, 2029 | $0.9745 | $0.4113 | $1.7435 | -13.76% |
| June, 2029 | $4.2888 | $0.7756 | $4.5388 | +279.54% |
| July, 2029 | $3.6941 | $1.982 | $5.7029 | +226.91% |
| August, 2029 | $2.8183 | $2.4183 | $5.5862 | +149.41% |
| September, 2029 | $5.8326 | $2.8494 | $6.2726 | +416.16% |
| October, 2029 | $3.4479 | $3.4479 | $5.9236 | +205.12% |
| November, 2029 | $3.3321 | $2.93 | $4.0021 | +194.88% |
| December, 2029 | $1.8525 | $1.9125 | $4.8832 | +63.94% |
Actinium Pharmaceuticals Inc Stock (ATNM) Price Forecast for 2030
Actinium Pharmaceuticals Inc Stock (ATNM) is expected to reach an average price of $1.538 in 2030, with a high forecast of $1.9613 and a low forecast of $1.1147. This signifies an +36.11% surge from the last price of $1.13.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $1.7283 | $1.7504 | $1.6093 | +52.95% |
| February, 2030 | $1.714 | $1.7251 | $1.6472 | +51.69% |
| March, 2030 | $1.6198 | $1.7098 | $1.683 | +43.34% |
| April, 2030 | $1.8745 | $1.6877 | $1.7745 | +65.88% |
| May, 2030 | $2.0302 | $2.0802 | $1.9613 | +79.67% |
| June, 2030 | $1.746 | $1.917 | $1.9292 | +54.51% |
| July, 2030 | $1.8707 | $1.8449 | $1.9017 | +65.55% |
| August, 2030 | $1.4064 | $1.7964 | $1.8285 | +24.46% |
| September, 2030 | $1.6411 | $1.3143 | $1.5222 | +45.23% |
| October, 2030 | $1.2868 | $1.3578 | $1.38 | +13.88% |
| November, 2030 | $0.8526 | $1.1147 | $1.0558 | -24.55% |
| December, 2030 | $1.1373 | $1.1994 | $1.1283 | +0.64% |
4.22%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):